SCHEMBL7747584

SCHEMBL7747584

N[C@@H](CC(=O)O)c1ccc(Cl)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.44
CYP2C9 P11712 3/20 0.44
KMT2A Q03164 3/20 0.44
CYP2D6 P10635 3/20 0.44
MEN1 O00255 2/20 0.44
CYP2C19 P33261 2/20 0.44
GABBR2 O75899 3/20 0.42
GABBR1 Q9UBS5 3/20 0.42
LMNA P02545 2/20 0.42
CYP3A4 P08684 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
NFKB1 P19838 1/20 0.42
DRD3 P35462 1/20 0.42
BLM P54132 1/20 0.42
CYP1A2 P05177 1/20 0.42
THRB P10828 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
FFAR1 O14842 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101478 0.81 NAPRT (0.46) NAPRTCYP2C9KMT2ACYP2D6MEN1
SCHEMBL5041305 0.80 SMN1; SMN2 (0.41) CYP2C9KMT2ACYP2D6MEN1CYP2C19
SCHEMBL5041302 0.80 SMN1; SMN2 (0.41) CYP2C9KMT2ACYP2D6MEN1CYP2C19
Hydrochloric Acid SCHEMBL31297444 0.77 CYP3A4 (0.41) NAPRTCYP2D6CYP3A4SLC6A2SLC6A4
SCHEMBL13049949 0.77 NAPRT (0.48) NAPRTCYP2C9KMT2ACYP2D6MEN1
SCHEMBL390336 0.77 CYP2C9 (0.64) CYP2C9KMT2ACYP2D6MEN1CYP2C19
SCHEMBL390335 0.77 CYP2C9 (0.64) CYP2C9KMT2ACYP2D6MEN1CYP2C19
SCHEMBL5721009 0.77 CYP2C9 (0.64) CYP2C9KMT2ACYP2D6MEN1CYP2C19
SCHEMBL27764921 0.77 CYP3A4 (0.47) NAPRTCYP2D6CYP3A4SLC6A2SLC6A4
SCHEMBL24168651 0.76 P2RX7 (0.44) KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133489-A1 ISONIPECOTAMIDES FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS Ortho-McNeil Pharmaceutical, Inc. (US) 2001-09-19 EP disclosed
WO-2001023376-A1 ISONIPECOTAMIDES FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-04-05 WO disclosed